INTERVIEW | Dr James Campbell on Proactive


Patrys CEO and MD, Dr James Campbell, was interviewed by Proactive’s Andrew Scott to discuss the importance of today’s announcement that batch specification testing for GMP PAT-DX1 material has been successfully completed.

He also provided an overview of upcoming activities, as Patrys prepares to initiate a phase 1 clinical study of PAT-DX1 in the second half of 2023.

Check out the interview here: